Pentapeptide-3 (Vialox®) he peptide synthetic e hana ana me he mea anti-wrinkle.
Ua hoʻoulu ʻia kona hoʻolālā e kahi moʻo moʻo (Tropidolaemus wagleri) mea ʻawaʻawa peptide.
ʻO kēia mīkini ke kumu no kāna hoʻohana kaulana i nā mea hoʻonaninani e hōʻemi i nā wrinkles ʻili a me ka laxity.
Kaʻina
Gly-Pro-Arg-Pro-Ala-NH2
Helu CAS
135679-88-8
ʻĀpana Molekala
C21H37N9O5
Kaumaha Molekala
495.58
ʻO ka noiʻi pili Pentapeptide-3
1.ʻIkepili lāʻau lapaʻau a me ka hoʻomohala ʻana
Hōʻike ʻo ia i ka emi nui ʻana ʻawaʻawa (ma kahi o 1,000 paʻi) hoʻohālikelike ʻia me ka peptide ʻawaʻawa e hoʻohālikelike ai i ka hoʻopaʻa ʻana nā mea loaʻa acetylcholine.
He mea hoʻokūkū hoʻokūkū o ka acetylcholine receptor a me nā hana ma ke kāohi ʻana i ka neʻe neuromuscular, e alakaʻi ana i ka emi ʻana o ka ʻiʻo.
Ua ʻōlelo ʻia ʻo Pentapeptide-3 he ʻano hana like me ka tubocurarine, he ʻawaʻawa ʻawaʻawa loa i loaʻa mai nā mea kanu he nui.
He ʻokoʻa i ka unuhi pololei ʻana mai ka snake venom, Hoʻopili ʻia ka pentapeptide-3 i kūʻai ʻia ma ke ʻano o ke kaʻina hana kemika.
ʻO kēia ka mea e hōʻoia i ka maʻemaʻe a me ka palekana, ka pale ʻana i nā pilikia e pili ana me nā mea ʻino ʻē aʻe i loaʻa i loko o ka lāʻau make maoli.
2.Mechanism kiko'ī o ka hana
ʻO ke ʻano hana mua no ka pentapeptide-3 ʻo ia ka poloka NMJ hōʻailona.
Ma lalo o nā kūlana hana maʻamau, hoʻokuʻu ʻia nā puʻupuʻu makaʻu e hiki mai ana i ka hoʻokuʻu ʻana o nā aʻalolo a neurotransmitter ʻike ʻia ʻo acetylcholine.
Hoʻokuʻu ʻia ka Acetylcholine, keʻaʻa i ka synapse a hoʻopaʻa i nicotinic acetylcholine receptors (nAChR) ma luna o ka membrane cell muscle (ka membrane postsynaptic).
ʻO kēia hoʻopaʻa ʻana e alakaʻi i ka hoʻāla ʻana o nā kaila ion receptor, e hiki ai ke komo i na ion Na+.
ʻO kēia ka hopena i loko depolarization ʻo ka membrane cell muscle a alakaʻi i nā hoʻololi biochemical e hoʻohaʻahaʻa ai i ka fiber muscle.
ʻO Pentapeptide-3 kahi mea hoʻokūkū hoʻokūkū o ka ʻiʻo nicotinic acetylcholine receptor (nAChR), ka pale ʻana i ka hoʻopaʻa ʻana o ka acetylcholine i kēia mau mea loaʻa.
Kāohi kēia hana i ka wehe ʻana o nā kaha sodium i hoʻopaʻa ʻia, ʻo ia hoʻi ka hoʻopaʻa ʻana i ka depolarization o ka membrane postsynaptic a me ka hopena i ka emi ʻana o ka pinepine a me ka ikaika o ka ʻoki ʻana o ka ʻiʻo..
3.In Vitro and Clinical Efficacy
Ua hōʻike ʻia nā hoʻokolohua in vitro i ka emi ʻana o ka ʻiʻo ʻana o ka ʻiʻo ma o 71% ma hope o hoʻokahi minuke wale nō a me ka helu hoʻopaʻa ʻana o 58 pākēneka ma hope o ʻelua hola.
Hāʻawi ʻia i hoʻomohala ʻia nā wrinkles maka e ka hoʻopaʻa pinepine ʻana o nā ʻiʻo subcutaneous, Hiki i kēia ala ke hoʻomaha i nā ʻiʻo subcutaneous e hōʻemi i ka hohonu o nā wrinkles ikaika, e like me kapuaʻi keu.
Hoʻohana nui ʻia ka Pentapeptide-3 i ka mālama ʻili anti-aging.
Ua hōʻoia ʻia ka maikaʻi ma nā hoʻokolohua lapaʻau he nui.
COA
HPLC
MS





